Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedJan 09, 2026
DataAggregated Company Financials
Companies14
  • 7D2.6%
  • 3M11.5%
  • 1Y25.8%
  • YTD3.7%

Over the last 7 days, the Pharma industry has risen 2.6%, driven by gains from AstraZeneca of 2.8%. This means that the industry has gained 26% over the past year. As for the next few years, earnings are expected to grow by 10% per annum.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 09 Jan 2026UK£334.5bUK£89.5bUK£14.6b21.8x22.9x3.7x
Sun, 07 Dec 2025UK£321.1bUK£89.8bUK£14.7b21.1x21.9x3.6x
Tue, 04 Nov 2025UK£300.6bUK£89.2bUK£13.9b20.9x21.6x3.4x
Thu, 02 Oct 2025UK£296.2bUK£87.6bUK£11.7b19.7x25.3x3.4x
Sat, 30 Aug 2025UK£280.1bUK£87.4bUK£11.7b21.3x24x3.2x
Mon, 28 Jul 2025UK£263.5bUK£86.6bUK£10.7b29.8x24.7x3x
Wed, 25 Jun 2025UK£258.5bUK£86.1bUK£10.6b26x24.5x3x
Fri, 23 May 2025UK£262.6bUK£86.7bUK£10.7b26.7x24.6x3x
Sun, 20 Apr 2025UK£252.1bUK£86.5bUK£9.6b26.7x26.3x2.9x
Tue, 18 Mar 2025UK£290.1bUK£87.5bUK£9.6b28.9x30.3x3.3x
Thu, 13 Feb 2025UK£285.3bUK£89.4bUK£9.5b30.8x29.9x3.2x
Sat, 11 Jan 2025UK£233.0bUK£76.6bUK£7.9b32x29.4x3x
Mon, 09 Dec 2024UK£227.6bUK£74.8bUK£7.7b32.1x29.5x3x
Wed, 06 Nov 2024UK£221.0bUK£72.2bUK£7.5b31.1x29.3x3.1x
Fri, 04 Oct 2024UK£252.7bUK£72.1bUK£9.0b30.8x28x3.5x
Sun, 01 Sep 2024UK£280.9bUK£72.0bUK£9.0b42x31.3x3.9x
Tue, 30 Jul 2024UK£262.8bUK£72.2bUK£9.6b34.7x27.5x3.6x
Thu, 27 Jun 2024UK£267.6bUK£71.8bUK£9.6b30.4x27.9x3.7x
Sat, 25 May 2024UK£270.8bUK£71.4bUK£9.6b31.9x28.3x3.8x
Mon, 22 Apr 2024UK£244.3bUK£71.6bUK£9.8b31.8x24.9x3.4x
Wed, 20 Mar 2024UK£235.7bUK£70.5bUK£9.7b31.5x24.2x3.3x
Fri, 16 Feb 2024UK£226.9bUK£69.8bUK£9.6b35.1x23.6x3.3x
Sun, 14 Jan 2024UK£244.2bUK£68.8bUK£10.6b36.8x22.9x3.5x
Tue, 12 Dec 2023UK£227.0bUK£69.4bUK£10.7b33.3x21.1x3.3x
Thu, 09 Nov 2023UK£229.3bUK£70.6bUK£11.0b53.2x20.8x3.2x
Sat, 07 Oct 2023UK£244.8bUK£70.4bUK£10.4b74.9x23.6x3.5x
Mon, 04 Sep 2023UK£236.9bUK£69.4bUK£10.2b53.5x23.2x3.4x
Wed, 02 Aug 2023UK£243.5bUK£68.7bUK£10.2b52.8x23.9x3.5x
Fri, 30 Jun 2023UK£243.9bUK£68.1bUK£7.9b55.1x30.9x3.6x
Sun, 28 May 2023UK£251.7bUK£68.9bUK£8.0b55.5x31.5x3.7x
Tue, 25 Apr 2023UK£261.8bUK£69.2bUK£6.9b63.2x38.2x3.8x
Thu, 23 Mar 2023UK£239.8bUK£69.9bUK£6.9b52.7x34.7x3.4x
Sat, 18 Feb 2023UK£251.1bUK£70.5bUK£7.2b57.8x34.8x3.6x
Mon, 16 Jan 2023UK£252.3bUK£79.6bUK£6.3b39x40x3.2x
Price to Earnings Ratio

40x


Total Market Cap: UK£252.3bTotal Earnings: UK£6.3bTotal Revenue: UK£79.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 27.1x202420252026
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 22.9x which is lower than its 3-year average PE of 27.1x.
  • The 3-year average PS ratio of 3.4x is lower than the industry's current PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 32% per year over the last three years.
  • Revenues for these companies have grown 4.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.28%
Healthcare2.61%
Pharma2.61%
Pharma2.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£141.762.8%
+UK£6.0b		29.0%PE31.4x
GSK GSKUK£18.913.6%
+UK£2.7b		40.1%PE13.8x
HCM HUTCHMED (China)UK£2.184.8%
+UK£86.0m		-14.5%PE5.4x
AGY Allergy TherapeuticsUK£0.127.3%
+UK£49.1m		63.9%PS13.2x
ANCR Animalcare GroupUK£2.536.8%
+UK£11.0m		2.8%PE58.6x

Latest News

HLN
UK£3.72
Haleon
7D
-0.8%
1Y
-2.9%
AZN
UK£141.76
AstraZeneca
7D
2.8%
1Y
29.0%
GSK
UK£18.91
GSK
7D
3.6%
1Y
40.1%

GSK: Limited Pipeline Readouts Will Cap Multiple Expansion Potential

Analysts have lifted their implied fair value for GSK from £11.20 to £14.55 per share, while trimming long term revenue growth and margin assumptions. They have also assigned a higher future P/E in light of recent price target moves and concerns about limited pipeline readouts and the new CEO's room to maneuver.
HCM
UK£2.18
HUTCHMED (China)
7D
4.8%
1Y
-14.5%
AGY
UK£0.12
Allergy Therapeutics
7D
7.3%
1Y
63.9%
ANCR
UK£2.53
Animalcare Group
7D
6.8%
1Y
2.8%
EAH
UK£1.04
ECO Animal Health Group
7D
-1.0%
1Y
51.1%

Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%

Dec 04
Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%
POLB
UK£0.043
Poolbeg Pharma
7D
7.5%
1Y
-23.2%
SAR
UK£0.20
Sareum Holdings
7D
33.3%
1Y
-11.1%
IMM
UK£0.072
ImmuPharma
7D
15.8%
1Y
105.1%
N4P
UK£0.005
N4 Pharma
7D
-4.8%
1Y
-16.7%